Elmiron
NDC Package 54868-4525-2
Package Information
Elmiron is a medication used to treat pain/discomfort from a certain bladder disorder (interstitial cystitis). Marketed by Physicians Total Care, Inc., this product is identified by NDC 54868-4525 and is authorized under FDA application NDA020193.
Identification & Billing
- RxCUI: 199498 - pentosan polysulfate sodium 100 MG Oral Capsule
- RxCUI: 199498 - pentosan polysulfate 100 MG Oral Capsule
- RxCUI: 211140 - Elmiron 100 MG Oral Capsule
- RxCUI: 211140 - pentosan polysulfate 100 MG Oral Capsule [Elmiron]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 54868 - Physicians Total Care, Inc.
- 54868-4525 - Elmiron
- 54868-4525-2 - 10 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC
- 54868-4525 - Elmiron
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (54868-4525). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54868-4525-2 identifies a specific commercial package of 10 capsule, gelatin coated in 1 bottle, plastic of Elmiron, labeled by Physicians Total Care, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 10 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Physicians Total Care, Inc. on December 17, 2003. The current certification is valid through December 31, 2017.
What are the primary indications for this medication?
This medication is used to treat pain/discomfort from a certain bladder disorder (interstitial cystitis). It may work by forming a layer on the bladder wall and protecting it from harmful/irritating substances in the urine. It is also a weak "blood thinner" and therefore may increase the risk of bruising/bleeding (such as bleeding from the nose/gums).
How is this Physicians Total Care, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54868452502. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.